New bearings in pharmacotherapeutic strategies: Pharmacogenetics and gene therapy

New bearings in pharmacotherapeutic strategies: Pharmacogenetics and gene therapy

Bibliographic Details
Main Authors:	Grbović Leposava, Radenković Miroslav, Đokić Jelena, Gojković-Bukarica Ljiljana, Dragović Gordana J.
Format:	Article
Language:	English
Published:	Military Health Department, Ministry of Defance, Serbia 2007-01-01
Series:	Vojnosanitetski Pregled
Subjects:	pharmacology clinical pharmacogenetics genome viral polymorphism genetic gene therapy
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2007/0042-84500710707G.pdf

Similar Items

Pharmacogenetics of antiretroviral drugs
by: Dragović Gordana, et al.
Published: (2012-01-01)

Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization
by: Kristina A. Malsagova, et al.
Published: (2020-12-01)

A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From China
by: Chengxian Guo, et al.
Published: (2021-07-01)

PHARMACOGENETICS – THE FUTURE OF THE DRUG THERAPY
by: Slobodan Jankovic, et al.
Published: (2007-10-01)

Pharmacogenetics in schizophrenia: a review of clozapine studies
by: Fabiana Barzotti Kohlrausch
Published: (2013-09-01)

Opportunities of the pharmacogenetic approach to personalized tamoxifen breast cancer therapy: case reports
by: Marina I Savelyeva, et al.
Published: (2019-03-01)

Pharmacogenetics in Clinical Practice
by: Hana Bakhouche, et al.
Published: (2012-01-01)

Application of pharmacogenetics in oncology
by: Nelly N. Miteva-Marcheva, et al.
Published: (2020-08-01)

Next-Generation Sequencing in Pharmacogenetics/genomics
Published: (2020)

Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations
by: Rosario Dominguez Crespo Hirata, et al.
Published: (2018-11-01)

Functional analysis of the Rad51d (E233G) breast cancer associated polymorphism and a pharmacogenetic evaluation of RAD51D status
by: Nadkarni, Aditi A.
Published: (2008)

Whole genome amplification of DNA for genotyping pharmacogenetics candidate genes.
by: Santosh ePhilips, et al.
Published: (2012-03-01)

Pharmacogenetics Research and Clinical Applications: An International Landscape of the Accomplishments, Challenges, and Opportunities
Published: (2020)

Establishment of a Pharmacogenetics Service Focused on Optimizing Existing Pharmacogenetic Testing at a Large Academic Health Center
by: Amy L. Pasternak, et al.
Published: (2020-10-01)

Pharmacogenetic Testing in Acute and Chronic Pain: A Preliminary Study
by: Lorenzo Panella, et al.
Published: (2019-05-01)

Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
by: Juan Pablo Cayún Pellizaris, et al.
Published: (2014-11-01)

Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase
by: Felicia Stefania Falvella, et al.
Published: (2015-04-01)

Pharmacogenetics from ethno-cultural perspectives
by: Chee Ng, et al.
Published: (2010-12-01)

Exploring a Laboratory Model of Pharmacogenetics as Applied to Clinical Decision Making
by: David F. Kisor, et al.
Published: (2013-01-01)

Exploring a Laboratory Model of Pharmacogenetics as Applied to Clinical Decision Making
by: Angela Smith, PharmD Candidate, et al.
Published: (2013-01-01)

Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review
by: Emiliene B. Tata, et al.
Published: (2020-08-01)

Organo-protective effects of quinapril: pharmacogenetic aspects
by: D. A. Sychev, et al.
Published: (2011-04-01)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
by: Shusuke Numata, et al.
Published: (2018-09-01)

Pharmacogenetics of antidepressant response: An update
by: Drago Antonio, et al.
Published: (2009-04-01)

Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research
by: Aizati N. A. Daud, et al.
Published: (2017-04-01)

Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications
by: Zhang F, et al.
Published: (2019-07-01)

Pharmacogenetics and pharmacogenomics: The impact of the single nucleotide polymorphisms in drug response
by: Jančić Ivan, et al.
Published: (2015-01-01)

Pharmacogenetics of OATP Transporters Reveals That SLCO1B1 c.388A>G Variant Is Determinant of Increased Atorvastatin Response
by: Rosario D. C. Hirata, et al.
Published: (2011-09-01)

Pharmacogenetics from ethno-cultural perspectives
by: Chee Ng, et al.
Published: (2010-12-01)

10 Years of Pharmacogenetics and Pharmacogenomics
Published: (2020)

Pharmacogenetics of FSH Action in the Male
by: Maria Schubert, et al.
Published: (2019-02-01)

Type 2 diabetes mellitus: Clinical aspects of genetics, nutrigenetics, and pharmacogenetics
by: A S Ametov, et al.
Published: (2015-08-01)

PEG-Interferon-α ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study
by: Javier Milara, et al.
Published: (2015-01-01)

A study of elective genome sequencing and pharmacogenetic testing in an unselected population
by: Meagan Cochran, et al.
Published: (2021-09-01)

Examining the Influence and Role of Pharmacogenetics among Children with Autism Spectrum Disorder
by: Shaker, Nuha
Published: (2017)

Pharmacogenetics and its clinical applications in opioid therapy
by: Caterina Aurilio, et al.
Published: (2008-12-01)

OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
by: Miles Douglas Thompson, et al.
Published: (2014-05-01)

The basic principals of pharmacogenetics testing in cancer treatment
by: Cikota-Aleksić Bojana M., et al.
Published: (2020-01-01)

Pharmacogenetic Impact on Metabolism and Cytochrome P450 (CYP)3A Inductive Effect of Tamoxifen
by: Mugundu, Ganesh
Published: (2009)

Pharmacogenetics, pharmacogenomics and airway disease
by: Hall Ian P
Published: (2001-11-01)

Cannot write session to /tmp/vufind_sessions/sess_vqaekac3qb2gjkgpkptjjtgi5v